An oversight hearing held by the Senate’s Judiciary Subcommittee on Antitrust, Competition Polity and Consumer Rights had DOJ antitrust head William Baer focusing on so-called most-favored-nation clauses, adding that the Federal Trade Commission will also be focusing on the issue. The clauses are said to hamper competition particularly in the healthcare sector, as health providers discriminate against health insurers and prices rise for those in need of healthcare. Baer recognized that federal enforcement and public discussion can be credited with growing interest of the MFN clause.
Featured News
Senate Committee Advances Quantum Computing Bill
Apr 15, 2026 by
CPI
EU Tightens Grip on Big Tech with New Age Verification App
Apr 15, 2026 by
CPI
EU Moves to Force Meta to Restore Rival AI Access on WhatsApp
Apr 15, 2026 by
CPI
South Korea Nears Conclusion of Gas Station Collusion Probe Amid Rising Oil Prices
Apr 15, 2026 by
CPI
Westlake Agrees to $67 Million Settlement in US PVC Pipe Antitrust Case
Apr 15, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Competitor Collaborations
Mar 26, 2026 by
CPI
Between Scylla and Charybdis – Navigating Transatlantic Antitrust Currents
Mar 26, 2026 by
Tilman Kuhn & Niklas Brüggemann
Cartel Enforcement Moves Into the Labor Market: Trends and Implications
Mar 26, 2026 by
Andreas Kafetzopoulos & Caroline Janssens
Rethinking Buy-Side Antitrust “Group Boycotts”
Mar 26, 2026 by
Craig Falls & Brendan McGuire
Positive Collaborations: The Tools Available to Competition Authorities to Encourage Beneficial Interactions Between Competitors
Mar 26, 2026 by
Rona Bar-Isaac & Thomas Withers